【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 9
1.1 List of Tables 15
1.2 List of Figures 17
2 Introduction 18
2.1 Catalyst 18
2.2 Related Reports 18
3 Disease Overview 19
3.1 Etiology and Pathophysiology 19
3.1.1 Etiology 19
3.1.2 Pathophysiology 20
3.2 Symptoms 22
3.3 Diagnosis 22
3.4 Prognosis 23
3.5 Quality of Life 23
4 Epidemiology 25
4.1 Disease Background 25
4.1.1 GHD in Children 25
4.1.2 GHD in Adults 26
4.2 Risk Factors and Comorbidities 26
4.3 Global Trends 28
4.3.1 GHD in Children 29
4.3.2 GHD in Adults 31
4.4 Forecast Methodology 32
4.4.1 Sources Used 36
4.4.1.1 7MM 36
4.4.1.2 Diagnosed Cases of GHD in Children 37
4.4.1.3 Diagnosed Cases of GHD in Adults 38
4.4.1.4 GHD Etiological Classification in Children 38
4.4.1.5 GHD Etiological Classification in Adults 39
4.4.2 Sources Not Used 40
4.4.3 Forecast Assumptions and Methods 41
4.4.3.1 Temporal Trends 41
4.4.3.2 Sex-Specific Trends 41
4.4.3.3 Diagnosed Prevalent Cases of GHD in Children 41
4.4.3.4 Diagnosed Prevalent Cases of GHD in Adults 42
4.4.3.5 GHD Etiological Classification in Children 43
4.4.3.6 GHD Etiological Classification in Adults 43
4.5 Epidemiological Forecast of GHD (2014-2024) 44
4.5.1 Diagnosed Prevalent Cases of GHD 44
4.5.2 Diagnosed Prevalent Cases of GHD by Sex 46
4.5.3 Diagnosed Prevalent Cases of GHD by Age 47
4.5.3.1 Diagnosed Prevalent Cases of GHD in Children 47
4.5.3.2 Diagnosed Prevalent Cases of GHD in Adults 49
4.5.4 Age-Adjusted Diagnosed Prevalence of GHD 50
4.5.5 Diagnosed Prevalent Cases of GHD in Children by Etiological Classification 51
4.5.6 Diagnosed Prevalent Cases of GHD in Adults by Etiological Classification 52
4.6 Discussion 53
4.6.1 Epidemiological Forecast Insight 53
4.6.2 Limitations of the Analysis 54
4.6.3 Strengths of the Analysis 55
5 Competitive Assessment 56
5.1 Overview 56
5.2 Treatment Algorithm 56
5.3 Market Access, Reimbursement, and Clinical Practice 58
5.4 Product Profiles — Recombinant Human Growth Hormones 60
5.4.1 Overview 60
5.4.1.1 Genotropin 61
5.4.1.2 Humatrope 62
5.4.1.3 Norditropin 62
5.4.1.4 Nutropin AQ 63
5.4.1.5 Saizen 64
5.4.1.6 Tev-Tropin/Zomacton/Growject 64
5.4.1.7 Omnitrope Biosimilar 65
5.4.2 Efficacy 68
5.4.2.1 Pediatric GHD 68
5.4.2.2 Adult GHD 68
5.4.3 Safety 69
5.4.3.1 Pediatric GHD 69
5.4.3.2 Adult GHD 69
5.4.4 SWOT Analysis 70
6 Unmet Needs Assessment and Opportunity Analysis 71
6.1 Overview 71
6.2 Improved Adherence and Compliance 72
6.2.1 Unmet Needs 72
6.2.2 Gap Analysis 74
6.2.3 Opportunity 74
6.3 Early Diagnosis 75
6.3.1 Unmet Needs 75
6.3.2 Gap Analysis 75
6.3.3 Opportunity 76
6.4 Disease Awareness and Regulatory Policy in Japan 76
6.4.1 Unmet Needs 76
6.4.2 Gap Analysis 77
6.4.3 Opportunity 77
6.5 Insurance Policies that Impact Patient Access 78
6.5.1 Unmet Needs 78
6.5.2 Gap Analysis 79
6.5.3 Opportunity Analysis 79
6.6 Safer Treatments for Cancer Survivors 79
6.6.1 Unmet needs 79
6.6.2 Gap Analysis 80
6.6.3 Opportunity Analysis 80
7 R&D Strategies 81
7.1 Overview 81
7.1.1 Development of Long-Acting Biobetter Growth Hormones 81
7.1.2 Novel Drug Delivery Strategies 82
7.1.3 Targeting the Growth Hormone Releasing Hormone 83
7.1.4 Licensing and Acquisitions 83
7.2 Clinical Trial Design 84
7.2.1 Current Clinical Trial Design 84
7.2.2 Future Clinical Trial Design 85
8 Pipeline Assessment 88
8.1 Overview 88
8.2 Promising Drugs in Clinical Development 89
8.2.1 Somatropin Biopartners 91
8.2.1.1 Overview 91
8.2.1.2 Efficacy 92
8.2.1.3 Safety 92
8.2.1.4 SWOT Analysis 93
8.2.2 NNC0195-0092 93
8.2.2.1 Overview 93
8.2.2.2 Efficacy 95
8.2.2.3 Safety 95
8.2.2.4 SWOT Analysis 95
8.2.3 MOD-4023 96
8.2.3.1 Overview 96
8.2.3.2 Efficacy 97
8.2.3.3 Safety 97
8.2.3.4 SWOT Analysis 98
8.2.4 VRS-317 98
8.2.4.1 Overview 98
8.2.4.2 Efficacy 99
8.2.4.3 Safety 99
8.2.4.4 SWOT Analysis 100
8.2.5 ACP-001 100
8.2.5.1 Overview 100
8.2.5.2 Efficacy 101
8.2.5.3 Safety 101
8.2.5.4 SWOT Analysis 102
8.2.6 TV-1106 102
8.2.6.1 Overview 102
8.2.6.2 Efficacy 103
8.2.6.3 Safety 103
8.2.6.4 SWOT Analysis 104
8.3 Innovative Early-Stage Approaches 104
9 Pipeline Valuation Analysis 107
9.1 Clinical Benchmark of Key Pipeline Drugs 107
9.2 Commercial Benchmark of Key Pipeline Drugs 109
9.3 Competitive Assessment 112
9.4 Top Line Ten Year Forecast 113
9.4.1 US 118
9.4.2 5EU 119
9.4.3 Japan 120
10 Appendix 122
10.1 Bibliography 122
10.2 Abbreviations 130
10.3 Methodology 133
10.4 Forecasting Methodology 133
10.4.1 Diagnosed GHD patients 133
10.4.2 Percent Drug-Treated Patients 133
10.4.3 Drugs Included in Each Therapeutic Class 134
10.4.4 Launch and Patent Expiry Dates 134
10.4.5 General Pricing Assumptions 135
10.4.6 Individual Drug Assumptions 136
10.4.7 Pricing of Pipeline agents 139
10.5 Physicians Included in This Study 141
10.6 Payers Included in This Study 142
10.7 Primary Research – Prescriber Survey 143
10.8 About the Authors 144
10.8.1 Analyst 144
10.8.2 Epidemiologist 144
10.8.3 Therapy Director – CVMD 145
10.8.4 Global Head of Healthcare 145
10.9 About GlobalData 146
10.10 Disclaimer 146
【レポート販売概要】
■ タイトル：成長ホルモン分泌不全症治療薬の世界市場機会分析■ 英文：OpportunityAnalyzer: Growth Hormone Deficiency - Opportunity Analysis and Forecast to 2024
■ 発行日：2015年8月1日
■ 調査会社：GlobalData
■ 商品コード：GDHC029POA
■ 調査対象地域：グローバル
- 世界の眼内レンズ (IOL)開発動向：医療機器パイプライン分析2015Intra Ocular Lens (IOL) - Medical Devices Pipeline Assessment, 2015 Summary GlobalData's Medical Devices sector report, “Intra Ocular Lens (IOL) - Medical Devices Pipeline Assessment, 2015" provides an overview of Intra Ocular Lens (IOL) currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of …
- パーム油メチルエステルの世界市場The global palm methyl ester derivatives market is anticipated to reach USD 1.01 billion by 2025, according to a new report by Grand View Research, Inc. Growing demand for CPO and PKO derived products from a wide range of sectors including personal care, home care, and food along with other industrial products such as adhesives, lubricants, paints, coatings, and inks is expected to influence produ …
- 胃食道逆流症（GERD）治療薬の世界市場2016-2020About GERD Drugs Gastroesophageal reflux disease (GERD) is a chronic digestive disorder that affects the lower esophageal sphincter (LES), the ring of muscle between the stomach and esophagus. It occurs when acidic stomach juices, or food and fluids flow back up into the food pipe (esophagus). The backwash irritates the lining of the esophagus and causes GERD. It affects all ages from infants to o …
- 自動車用インテリジェントガラスの世界市場2019-2023Global Automotive Intelligent Glass Market: About this market Technavio’s automotive intelligent glass market analysis considers sales from heated glass, dimmable glass, and others. Our analysis also considers the sales of automotive intelligent glass in APAC, Europe, North America, South America, and MEA. In 2018, the heated glass segment had a significant market share, and this trend is expected …
- Enerplus Corporation：石油・ガスバリューチェーン分析レポート2013Enerplus Corporation Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Enerplus Corporation" Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Enerplus Corporation”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The report exam …
- 肝機能不全(Hepatic Insufficiency)：世界の治験レビュー（2015年上半期版）Hepatic Insufficiency Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Hepatic Insufficiency Global Clinical Trials Review, H1, 2015" provides data on the Hepatic Insufficiency clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hepatic Insufficiency. It includes an overview of the trial numbers and the …
- 萎縮性胃炎(Atrophic Gastritis)：世界の治験レビュー（2015年上半期版）Atrophic Gastritis Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Atrophic Gastritis Global Clinical Trials Review, H1, 2015" provides data on the Atrophic Gastritis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Atrophic Gastritis. It includes an overview of the trial numbers and their recruitme …
- 世界主要国におけるアエロモナス菌検査市場The report presents a detailed analysis of the Aeromonads diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Aeromonads definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments: - Hospitals - Co …
- GIS（地理情報システム）の世界市場2017-2021About GIS GIS (geographic information system) is a set of tools used to interpret business and geospatial data. It integrates hardware, software, data, and services for processing business and geographically referenced data. GIS digitizes the received geospatial data and processes them to provide the desired output. Sectors such as national government, transportation, natural resources, military/l …
- 世界の石油増進回収法(EOR)市場予測：熱攻法、ガス圧入法、ケミカル法Enhanced oil recovery (EOR) technologies are used to increase the amount of oil that can be extracted from an oil field after the primary and secondary production stages. The technologies play on the physics of how oil is trapped in the rocks and are primarily aimed at either decreasing the interfacial forces holding the oil in pores within the rock formation, reducing the viscosity difference bet …
- 世界の軍用機MRO市場2015-2025Summary The global military aviation MRO market is expected to be driven by aging fleets of military aircraft and helicopters, technological innovations, internal and external security threats, territorial disputes, and modernization initiatives undertaken by governments around the world. Cumulatively, the market is projected to value US$558.7 billion during 2015-2025 and is expected to be dominat …
- タンパク質ラベリングの世界市場：タンパク質標識試薬、タンパク質標識キット、サービスThe protein labeling market is expected to reach USD 1,894.5 Million by 2020 from USD 1,089.5 Million in 2015, growing at a CAGR of 11.7% from 2015 to 2020. A strong trend of increasing healthcare expenditure will majorly drive the growth of the market. Other growth factors include increasing R&D spending and growth in proteomics research. The increasing use of protein labeling in in vitro labelin …
- 空気・ガス漏れ検知器の世界市場2016-2020About Air Gas Leak Detectors Air and gas detectors are used to detect the presence of multiple gases in an area. The detectors help in detecting any flammable gases (such as methane and propane), kerosene or toxic gases (such as carbon monoxide, carbon dioxide, and sulphur dioxide), and oxygen depletion. These detectors are used to monitor gas leaks so that a process can be shut down in the event …
- 世界のビデオ監視ストレージ市場動向と予測（2013-2018）Video surveillance storage is one of the important parts of the video surveillance system setup. These storage devices are connected to the video cameras to save and record the feed. These storage devices contain storage media such as hard disk drives and solid state drives and get connected directly or over the network. The storage technologies include direct attached storage which can be impleme …
- Fibrinogen：医療検査市場2014The growing cost-containment pressures in major industrialized nations and continued technological advances will radically change coagulation testing practice during the next ten years. New specific and sensitive markers of hemostasis will be increasingly used on automated instrumentation. Coagulation testing in general, and Fibrinogen testing specifically, will become more standardized, offering …
